Abstract:Background Compound mutations of TNNT2R141W/+ (encoding troponin T) and MYPNS1296T/+ (encoding myopalladin) are associated with familial left ventricle non-compaction cardiomyopathy (LVNC). However, it remains unclear in which would be the pathogenic mutation, the underlying mechanism, and the target therapy for LVNC. Methods Knock-in C57BL/6J mice harboring mutations in orthologous genes in Tnnt2R154W or/and MypnS1291T and human cardiomyocytes derived from iPSC of healthy donors and LVNC patients (LVNC-hCM) were employed for disease modeling, omics analysis, mechanistic study, and drug development. Results Using knock-in mice for disease modeling, it was clarified that the orthologous mutation in Tnnt2, but not in Mypn, led to cardiac hypertrabeculation, noncompaction, and heart failure. 3D protein structure modeling by Swiss-model found a loss of slat bridge between TNNT2(R141W) and E-257 in tropomyosin, contributing to the decreased cardiac contraction. Further mechanistic study discovered that troponin T (TNNT2) appears to function as an HDAC1 sponge in cardiomyocyte nuclei. The compromised association between nuclear TNNT2(R141W) and HDAC1 causes cardiac epigenetic perturbation and subsequentially leads to transcriptional dysregulation. The downregulation of cardiac muscular genes was concomitant with the impairment of cardiac contraction, which would be partially rescued by pan HDAC inhibitor. Besides, the upregulation of TGFβ-signaling molecules and EZH2 did contribute to cardiac growth defects, which were mitigated by TGFβR1 inhibitor (A83-01) and EZH2 inhibitor (GSK503), respectively. Simvastatin, a hit drug identified from the repurposed drug screening, can restore nuclear TNNT2(R141W)-HDAC1 association, thereby recovering cardiac epigenetic, translational profiles, growth and function in LVNC-hCM in vitro and cardiac function in LVNC mice harboring Tnnt2R154W in vivo. The cardiac function was significantly improved in the proband receiving 5 mg once daily for consecutive two years. Conclusion Mutant TNNT2(R141W) diminished its nuclear HDAC1 sponge function in cardiomyocyte to induce LVNC pathogenesis through perturbating cardiac epigenetic and the gene expressions. Targeting to HDAC, TGFβ, EZH2 may rescue part of cardiac pathological signaling. Simvastatin can act as a chemical chaperone to comprehensively recover cardiac epigenetic via restoring nuclear TNNT2(R141W)-HDAC1 association.

Cardiac Overexpression of XIN Prevents Dilated Cardiomyopathy Caused by TNNT2 ΔK210 Mutation

Cardiac Overexpression Of Xin Prevents Dilated Cardiomyopathy Caused By Tnnt2 Delta K210 Mutation

NEXN Inhibits GATA4 and Leads to Atrial Septal Defects in Mice and Humans

Association Between SCN5A R225Q Variant and Dilated Cardiomyopathy: Potential Role of Intracellular Ph and WNT/β-catenin Pathway

In vivo rescue of genetic dilated cardiomyopathy by systemic delivery of nexilin

Targeting mutant TNNT2-induced epigenetic perturbation and pathogenic signaling in left ventricular non-compaction cardiomyopathy

Calponin1 Inhibits Dilated Cardiomyopathy Development in Mice Through the Εpkc Pathway.

Intercalated Disk Protein Xin-beta is Required for the Hippo/YAP Signaling in the Heart

Phenotype And Functional Analyses In A Transgenic Mouse Model Of Left Ventricular Noncompaction Caused By A Dtna Mutation

A Novel Tbx20 Loss-Of-Function Mutation Contributes to Adult-Onset Dilated Cardiomyopathy or Congenital Atrial Septal Defect

TBX5 Loss-of-function Mutation Contributes to Familial Dilated Cardiomyopathy

A Novel Nkx2-5 Loss-Of-Function Mutation Predisposes to Familial Dilated Cardiomyopathy and Arrhythmias

LncRNA ZNF593-AS Alleviates Contractile Dysfunction in Dilated Cardiomyopathy

Intercalated disc protein Xinβ is required for Hippo-YAP signaling in the heart

SLC7A11/xCT Prevents Cardiac Hypertrophy by Inhibiting Ferroptosis

Establishing a New Human Hypertrophic Cardiomyopathy-Specific Model Using Human Embryonic Stem Cells

Association Between AXIN1 Gene Polymorphisms and Dilated Cardiomyopathy in a Chinese Han Population.

Protective action of tetramethylpyrazine phosphate against dilated cardiomyopathy in cTnT R141W transgenic mice

TBX20 Loss-of-function Mutation Associated with Familial Dilated Cardiomyopathy.

Combinatorial Genetic Replenishments in Myocardial and Outflow Tract Tissues Restore Heart Function in Tnnt2 Mutant Zebrafish.

Knockdown of Cytochrome P450 2E1 Inhibits Oxidative Stress and Apoptosis in the Ctnt(r141w) Dilated Cardiomyopathy Transgenic Mice.